DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) SHH
16.31
-0.36(-2.16%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 20.15B |
| Enterprise Value | 26.5B |
| P/E Ratio | 14.48 |
| PEG Ratio | 0.44 |
| Price/Sales Ratio | 0.68 |
| Price/Book Ratio | 2.37 |
| Enterprise/Revenue | 0.52 |
| Enterprise/EBITDA | 7.15 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.05 |
| Operating Margin | 0.07 |
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.17 |
Income Statement
| Revenue | 27.5B |
| Revenue/Share | 24.23 |
| Gross Profit | 9.44B |
| EBITDA | 3.47B |
| Net Income | 1.24B |
| Diluted EPS | 1.08 |
Balance Sheet
| Total Cash | 7.11B |
| Total Cash/Share | 6.26 |
| Total Debt | 2.62B |
| Total Debt/Equity | 0.33 |
| Current Ratio | 0.93 |
| Book Value Per Share | 8.08 |
Price History
| 52-Week Change | -6.39 |
| 52-Week High | 21.78 |
| 52-Week Low | 15.34 |
| Moving Average 50 Days | 17.84 |
| Moving Average 200 Days | 18.14 |
Statistics
| Average Volume | 5.62M |
| Shares Outstanding | 1.14B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.65 |
| Trailing Annual Dividend Yield | 3.96 |
| Payout Ratio | 0.6 |
| Last Split Factor | 6:5 |
| Last Split Date | June 09, 2023 |
